Global Human Embryonic Stem Cells (HESC) Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global Human Embryonic Stem Cells (HESC) market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Human Embryonic Stem Cells (HESC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Human Embryonic Stem Cells (HESC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Human Embryonic Stem Cells (HESC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Human Embryonic Stem Cells (HESC) include ESI BIO, Thermo Fisher, Viacyte, Inc., UK Stem Cell Bank, TATAA Biocenter, Takara Bio, STEMCELL Technologies, Reliance Life Sciences and R&D Systems (Biotrchne), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Embryonic Stem Cells (HESC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Embryonic Stem Cells (HESC).

The Human Embryonic Stem Cells (HESC) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Embryonic Stem Cells (HESC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Human Embryonic Stem Cells (HESC) Segment by Company

ESI BIO
Thermo Fisher
Viacyte, Inc.
UK Stem Cell Bank
TATAA Biocenter
Takara Bio
STEMCELL Technologies
Reliance Life Sciences
R&D Systems (Biotrchne)
PerkinElmer
MilliporeSigma (Merck)
Fujifilm Cellular Dynamics
BioTime
BD Biosciences
Asterias Biotherapeutics
Astellas Institute of Regenerative Medicine
Human Embryonic Stem Cells (HESC) Segment by Type

Unipotent Stem Cells
Pluripotent Stem Cells
Totipotent Stem Cells
Human Embryonic Stem Cells (HESC) Segment by Application

Research
Clinical Trials
Others
Human Embryonic Stem Cells (HESC) Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Embryonic Stem Cells (HESC) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Embryonic Stem Cells (HESC) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Embryonic Stem Cells (HESC).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Embryonic Stem Cells (HESC) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Human Embryonic Stem Cells (HESC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Human Embryonic Stem Cells (HESC) Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Human Embryonic Stem Cells (HESC) Sales Estimates and Forecasts (2020-2031)
1.3 Human Embryonic Stem Cells (HESC) Market by Type
1.3.1 Unipotent Stem Cells
1.3.2 Pluripotent Stem Cells
1.3.3 Totipotent Stem Cells
1.4 Global Human Embryonic Stem Cells (HESC) Market Size by Type
1.4.1 Global Human Embryonic Stem Cells (HESC) Market Size Overview by Type (2020-2031)
1.4.2 Global Human Embryonic Stem Cells (HESC) Historic Market Size Review by Type (2020-2025)
1.4.3 Global Human Embryonic Stem Cells (HESC) Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Human Embryonic Stem Cells (HESC) Sales Breakdown by Type (2020-2025)
1.5.2 Europe Human Embryonic Stem Cells (HESC) Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Human Embryonic Stem Cells (HESC) Sales Breakdown by Type (2020-2025)
1.5.4 South America Human Embryonic Stem Cells (HESC) Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Human Embryonic Stem Cells (HESC) Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Human Embryonic Stem Cells (HESC) Industry Trends
2.2 Human Embryonic Stem Cells (HESC) Industry Drivers
2.3 Human Embryonic Stem Cells (HESC) Industry Opportunities and Challenges
2.4 Human Embryonic Stem Cells (HESC) Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Human Embryonic Stem Cells (HESC) Revenue (2020-2025)
3.2 Global Top Players by Human Embryonic Stem Cells (HESC) Sales (2020-2025)
3.3 Global Top Players by Human Embryonic Stem Cells (HESC) Price (2020-2025)
3.4 Global Human Embryonic Stem Cells (HESC) Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Human Embryonic Stem Cells (HESC) Major Company Production Sites & Headquarters
3.6 Global Human Embryonic Stem Cells (HESC) Company, Product Type & Application
3.7 Global Human Embryonic Stem Cells (HESC) Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Human Embryonic Stem Cells (HESC) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Embryonic Stem Cells (HESC) Players Market Share by Revenue in 2024
3.8.3 2023 Human Embryonic Stem Cells (HESC) Tier 1, Tier 2, and Tier 3
4 Human Embryonic Stem Cells (HESC) Regional Status and Outlook
4.1 Global Human Embryonic Stem Cells (HESC) Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Human Embryonic Stem Cells (HESC) Historic Market Size by Region
4.2.1 Global Human Embryonic Stem Cells (HESC) Sales in Volume by Region (2020-2025)
4.2.2 Global Human Embryonic Stem Cells (HESC) Sales in Value by Region (2020-2025)
4.2.3 Global Human Embryonic Stem Cells (HESC) Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Human Embryonic Stem Cells (HESC) Forecasted Market Size by Region
4.3.1 Global Human Embryonic Stem Cells (HESC) Sales in Volume by Region (2026-2031)
4.3.2 Global Human Embryonic Stem Cells (HESC) Sales in Value by Region (2026-2031)
4.3.3 Global Human Embryonic Stem Cells (HESC) Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Human Embryonic Stem Cells (HESC) by Application
5.1 Human Embryonic Stem Cells (HESC) Market by Application
5.1.1 Research
5.1.2 Clinical Trials
5.1.3 Others
5.2 Global Human Embryonic Stem Cells (HESC) Market Size by Application
5.2.1 Global Human Embryonic Stem Cells (HESC) Market Size Overview by Application (2020-2031)
5.2.2 Global Human Embryonic Stem Cells (HESC) Historic Market Size Review by Application (2020-2025)
5.2.3 Global Human Embryonic Stem Cells (HESC) Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Human Embryonic Stem Cells (HESC) Sales Breakdown by Application (2020-2025)
5.3.2 Europe Human Embryonic Stem Cells (HESC) Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Human Embryonic Stem Cells (HESC) Sales Breakdown by Application (2020-2025)
5.3.4 South America Human Embryonic Stem Cells (HESC) Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Human Embryonic Stem Cells (HESC) Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 ESI BIO
6.1.1 ESI BIO Comapny Information
6.1.2 ESI BIO Business Overview
6.1.3 ESI BIO Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 ESI BIO Human Embryonic Stem Cells (HESC) Product Portfolio
6.1.5 ESI BIO Recent Developments
6.2 Thermo Fisher
6.2.1 Thermo Fisher Comapny Information
6.2.2 Thermo Fisher Business Overview
6.2.3 Thermo Fisher Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Thermo Fisher Human Embryonic Stem Cells (HESC) Product Portfolio
6.2.5 Thermo Fisher Recent Developments
6.3 Viacyte, Inc.
6.3.1 Viacyte, Inc. Comapny Information
6.3.2 Viacyte, Inc. Business Overview
6.3.3 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Product Portfolio
6.3.5 Viacyte, Inc. Recent Developments
6.4 UK Stem Cell Bank
6.4.1 UK Stem Cell Bank Comapny Information
6.4.2 UK Stem Cell Bank Business Overview
6.4.3 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Product Portfolio
6.4.5 UK Stem Cell Bank Recent Developments
6.5 TATAA Biocenter
6.5.1 TATAA Biocenter Comapny Information
6.5.2 TATAA Biocenter Business Overview
6.5.3 TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 TATAA Biocenter Human Embryonic Stem Cells (HESC) Product Portfolio
6.5.5 TATAA Biocenter Recent Developments
6.6 Takara Bio
6.6.1 Takara Bio Comapny Information
6.6.2 Takara Bio Business Overview
6.6.3 Takara Bio Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Takara Bio Human Embryonic Stem Cells (HESC) Product Portfolio
6.6.5 Takara Bio Recent Developments
6.7 STEMCELL Technologies
6.7.1 STEMCELL Technologies Comapny Information
6.7.2 STEMCELL Technologies Business Overview
6.7.3 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Product Portfolio
6.7.5 STEMCELL Technologies Recent Developments
6.8 Reliance Life Sciences
6.8.1 Reliance Life Sciences Comapny Information
6.8.2 Reliance Life Sciences Business Overview
6.8.3 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Product Portfolio
6.8.5 Reliance Life Sciences Recent Developments
6.9 R&D Systems (Biotrchne)
6.9.1 R&D Systems (Biotrchne) Comapny Information
6.9.2 R&D Systems (Biotrchne) Business Overview
6.9.3 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Product Portfolio
6.9.5 R&D Systems (Biotrchne) Recent Developments
6.10 PerkinElmer
6.10.1 PerkinElmer Comapny Information
6.10.2 PerkinElmer Business Overview
6.10.3 PerkinElmer Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 PerkinElmer Human Embryonic Stem Cells (HESC) Product Portfolio
6.10.5 PerkinElmer Recent Developments
6.11 MilliporeSigma (Merck)
6.11.1 MilliporeSigma (Merck) Comapny Information
6.11.2 MilliporeSigma (Merck) Business Overview
6.11.3 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Product Portfolio
6.11.5 MilliporeSigma (Merck) Recent Developments
6.12 Fujifilm Cellular Dynamics
6.12.1 Fujifilm Cellular Dynamics Comapny Information
6.12.2 Fujifilm Cellular Dynamics Business Overview
6.12.3 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Product Portfolio
6.12.5 Fujifilm Cellular Dynamics Recent Developments
6.13 BioTime
6.13.1 BioTime Comapny Information
6.13.2 BioTime Business Overview
6.13.3 BioTime Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 BioTime Human Embryonic Stem Cells (HESC) Product Portfolio
6.13.5 BioTime Recent Developments
6.14 BD Biosciences
6.14.1 BD Biosciences Comapny Information
6.14.2 BD Biosciences Business Overview
6.14.3 BD Biosciences Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 BD Biosciences Human Embryonic Stem Cells (HESC) Product Portfolio
6.14.5 BD Biosciences Recent Developments
6.15 Asterias Biotherapeutics
6.15.1 Asterias Biotherapeutics Comapny Information
6.15.2 Asterias Biotherapeutics Business Overview
6.15.3 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Product Portfolio
6.15.5 Asterias Biotherapeutics Recent Developments
6.16 Astellas Institute of Regenerative Medicine
6.16.1 Astellas Institute of Regenerative Medicine Comapny Information
6.16.2 Astellas Institute of Regenerative Medicine Business Overview
6.16.3 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Product Portfolio
6.16.5 Astellas Institute of Regenerative Medicine Recent Developments
7 North America by Country
7.1 North America Human Embryonic Stem Cells (HESC) Sales by Country
7.1.1 North America Human Embryonic Stem Cells (HESC) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Human Embryonic Stem Cells (HESC) Sales by Country (2020-2025)
7.1.3 North America Human Embryonic Stem Cells (HESC) Sales Forecast by Country (2026-2031)
7.2 North America Human Embryonic Stem Cells (HESC) Market Size by Country
7.2.1 North America Human Embryonic Stem Cells (HESC) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Human Embryonic Stem Cells (HESC) Market Size by Country (2020-2025)
7.2.3 North America Human Embryonic Stem Cells (HESC) Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Human Embryonic Stem Cells (HESC) Sales by Country
8.1.1 Europe Human Embryonic Stem Cells (HESC) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Human Embryonic Stem Cells (HESC) Sales by Country (2020-2025)
8.1.3 Europe Human Embryonic Stem Cells (HESC) Sales Forecast by Country (2026-2031)
8.2 Europe Human Embryonic Stem Cells (HESC) Market Size by Country
8.2.1 Europe Human Embryonic Stem Cells (HESC) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Human Embryonic Stem Cells (HESC) Market Size by Country (2020-2025)
8.2.3 Europe Human Embryonic Stem Cells (HESC) Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Human Embryonic Stem Cells (HESC) Sales by Country
9.1.1 Asia-Pacific Human Embryonic Stem Cells (HESC) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Human Embryonic Stem Cells (HESC) Sales by Country (2020-2025)
9.1.3 Asia-Pacific Human Embryonic Stem Cells (HESC) Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Human Embryonic Stem Cells (HESC) Market Size by Country
9.2.1 Asia-Pacific Human Embryonic Stem Cells (HESC) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Human Embryonic Stem Cells (HESC) Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Human Embryonic Stem Cells (HESC) Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Human Embryonic Stem Cells (HESC) Sales by Country
10.1.1 South America Human Embryonic Stem Cells (HESC) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Human Embryonic Stem Cells (HESC) Sales by Country (2020-2025)
10.1.3 South America Human Embryonic Stem Cells (HESC) Sales Forecast by Country (2026-2031)
10.2 South America Human Embryonic Stem Cells (HESC) Market Size by Country
10.2.1 South America Human Embryonic Stem Cells (HESC) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Human Embryonic Stem Cells (HESC) Market Size by Country (2020-2025)
10.2.3 South America Human Embryonic Stem Cells (HESC) Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Human Embryonic Stem Cells (HESC) Sales by Country
11.1.1 Middle East and Africa Human Embryonic Stem Cells (HESC) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Human Embryonic Stem Cells (HESC) Sales by Country (2020-2025)
11.1.3 Middle East and Africa Human Embryonic Stem Cells (HESC) Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Human Embryonic Stem Cells (HESC) Market Size by Country
11.2.1 Middle East and Africa Human Embryonic Stem Cells (HESC) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Human Embryonic Stem Cells (HESC) Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Human Embryonic Stem Cells (HESC) Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Human Embryonic Stem Cells (HESC) Value Chain Analysis
12.1.1 Human Embryonic Stem Cells (HESC) Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Human Embryonic Stem Cells (HESC) Production Mode & Process
12.2 Human Embryonic Stem Cells (HESC) Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Human Embryonic Stem Cells (HESC) Distributors
12.2.3 Human Embryonic Stem Cells (HESC) Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings